Anti-BPI autoantibodies purified from CF or IBD sera prevent BPI-mediated phagocytosis and inhibit neutrophil-mediated killing of Gram-negative bacteria [19,78,[90], [91], [92]]. This evidence concerns the gene BPI and inflammatory bowel disease.